| 1 | EXECUTIVE SUMMARY |
| Overview of the Life Sciences Funding in Europe
1. Executive Summary of the Life Sciences Funding in Europe
|
| 2 | GLOSSARY |
| Key Acronyms
1. Terminologies and Acronyms
|
| 3 | RESEARCH METHODOLOGY |
| Assumptions and Methodology
1. Research Scope and Segmentation
|
| 4 | FUNDING IN EUROPE |
| Funding Landscape
1. Overview
Funding Scenario
1. European Funding Challenges
2. Measurements 3. Funding Analysis
4. Economic Stimulus in Europe
|
| 5 | FUNDING IN THE UNITED KINGDOM |
| Funding Overview
1. Introduction
Funding Scenario
1. Measurements
2. Funding Analysis
|
| 6 | FUNDING IN GERMANY |
| Funding Overview
1. Introduction
Funding Scenario
1. Measurements
2. Funding Analysis
|
| 7 | FUNDING IN FRANCE |
| Funding Overview
1. Introduction
Funding Scenario
1. Measurements
2. Funding Analysis
|
| 8 | FUNDING IN ITALY |
| Funding Overview
1. Introduction
Funding Scenario
1. Measurements
2. Funding Analysis
|
| 9 | FUNDING IN SPAIN |
| Funding Overview
1. Introduction
Funding Scenario
1. Measurements
2. Funding Analysis
|
| 10 | APPENDIX |
| Decision Support Database
1. Total Healthcare Expenditure
2. Government Healthcare Expenditure
3. Private Healthcare Expenditure
4. Number of Biotech Companies
5. Government Biotechnology R&D Investment
6. Venture Capital Biotechnology Investment
|
